UNLABELLED: Primary central nervous system lymphoma (PCNSL) is defined as the involvement of brain, leptomeninges, eyes or spinal cord by non-Hodgkin lymphoma. The role of various prognostic markers in predicting adverse outcome is debated. OBJECTIVES: To investigate the clinical and immunohistochemical findings of immunocompetent PCNSL cases (39 cases) diagnosed at the study center, and evaluate the influence of potential prognostic factors on overall survival (OS) of patients. METHODS: Data regarding patient characteristics, neuroimaging, pathological and immunohistochemical features and follow-up were obtained from patient records. The influence of potential prognostic parameters on OS was investigated by log-rank test and Cox regression analysis. RESULTS: Patients who received combined chemotherapy and radiotherapy had a significantly better OS when compared to chemotherapy alone. Other variables included in this study were not associated with a significant survival advantage. CONCLUSION: In this study, we failed to demonstrate a relationship between different clinicopathological variables and OS of patients. Prospective studies with large patient series are needed to investigate other potential prognostic factors.
UNLABELLED: Primary central nervous system lymphoma (PCNSL) is defined as the involvement of brain, leptomeninges, eyes or spinal cord by non-Hodgkin lymphoma. The role of various prognostic markers in predicting adverse outcome is debated. OBJECTIVES: To investigate the clinical and immunohistochemical findings of immunocompetent PCNSL cases (39 cases) diagnosed at the study center, and evaluate the influence of potential prognostic factors on overall survival (OS) of patients. METHODS: Data regarding patient characteristics, neuroimaging, pathological and immunohistochemical features and follow-up were obtained from patient records. The influence of potential prognostic parameters on OS was investigated by log-rank test and Cox regression analysis. RESULTS:Patients who received combined chemotherapy and radiotherapy had a significantly better OS when compared to chemotherapy alone. Other variables included in this study were not associated with a significant survival advantage. CONCLUSION: In this study, we failed to demonstrate a relationship between different clinicopathological variables and OS of patients. Prospective studies with large patient series are needed to investigate other potential prognostic factors.
Entities:
Keywords:
PCNSL; Primary central nervous system lymphoma; immunocompetent; prognosis; survival
Authors: Lauren E Abrey; Leah Ben-Porat; Katherine S Panageas; Joachim Yahalom; Brian Berkey; Walter Curran; Christopher Schultz; Steven Leibel; Diana Nelson; Minesh Mehta; Lisa M DeAngelis Journal: J Clin Oncol Date: 2006-11-20 Impact factor: 44.544
Authors: Kristoph Jahnke; Agnieszka Korfel; Brian Patrick O'Neill; Jean-Yves Blay; Lauren E Abrey; Peter Martus; Philip M P Poortmans; Tamara N Shenkier; Tracy T Batchelor; Edward A Neuwelt; Jeffrey J Raizer; David Schiff; Hendrik Pels; Ulrich Herrlinger; Harald Stein; Eckhard Thiel Journal: Ann Neurol Date: 2006-05 Impact factor: 10.422
Authors: Eyas M Hattab; Sarah E Martin; Sohaib M Al-Khatib; William J Kupsky; Gail H Vance; Ryan A Stohler; Magdalena Czader; Mousa A Al-Abbadi Journal: Mod Pathol Date: 2009-11-20 Impact factor: 7.842
Authors: S Bhagavathi; A Sharathkumar; S Hunter; L Sung; R Kanhere; M D Venturina; J D Wilson Journal: Clin Neuropathol Date: 2008 Jan-Feb Impact factor: 1.368
Authors: Ioannis Siasios; Aggeliki Fotiadou; George Fotakopoulos; Maria Ioannou; Vassilios Anagnostopoulos; Konstantinos Fountas Journal: J Clin Med Res Date: 2015-10-23